These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Phenotypic variability in Kennedy's disease: implication of the early diagnostic features. Lee JH; Shin JH; Park KP; Kim IJ; Kim CM; Lim JG; Choi YC; Kim DS Acta Neurol Scand; 2005 Jul; 112(1):57-63. PubMed ID: 15932358 [TBL] [Abstract][Full Text] [Related]
25. Biomarker-based analysis of preclinical progression in spinal and bulbar muscular atrophy. Hijikata Y; Hashizume A; Yamada S; Inagaki T; Ito D; Hirakawa A; Suzuki K; Atsuta N; Tsuboi T; Hattori M; Hori A; Banno H; Sobue G; Katsuno M Neurology; 2018 Apr; 90(17):e1501-e1509. PubMed ID: 29572281 [TBL] [Abstract][Full Text] [Related]
26. Pathogenesis and therapy of spinal and bulbar muscular atrophy (SBMA). Katsuno M; Tanaka F; Adachi H; Banno H; Suzuki K; Watanabe H; Sobue G Prog Neurobiol; 2012 Dec; 99(3):246-56. PubMed ID: 22609045 [TBL] [Abstract][Full Text] [Related]
27. Natural history of spinal-bulbar muscular atrophy. Chahin N; Klein C; Mandrekar J; Sorenson E Neurology; 2008 May; 70(21):1967-71. PubMed ID: 18490617 [TBL] [Abstract][Full Text] [Related]
29. Spinal and bulbar muscular atrophy and Charcot-Marie-Tooth type 1A: Co-existence of two rare neuromuscular genetic diseases in the same patient. Sagnelli A; Scaioli V; Piscosquito G; Salsano E; Dalla Bella E; Gellera C; Pareyson D Neuromuscul Disord; 2015 Oct; 25(10):800-1. PubMed ID: 26298608 [TBL] [Abstract][Full Text] [Related]
30. Myotonia-like symptoms in a patient with spinal and bulbar muscular atrophy. Araki K; Nakanishi H; Nakamura T; Atsuta N; Yamada S; Hijikata Y; Hashizume A; Suzuki K; Katsuno M; Sobue G Neuromuscul Disord; 2015 Nov; 25(11):913-5. PubMed ID: 26363965 [TBL] [Abstract][Full Text] [Related]
31. Tongue pressure as a novel biomarker of spinal and bulbar muscular atrophy. Mano T; Katsuno M; Banno H; Suzuki K; Suga N; Hashizume A; Araki A; Watanabe H; Tanaka S; Yamamoto M; Sobue G Neurology; 2014 Jan; 82(3):255-62. PubMed ID: 24353334 [TBL] [Abstract][Full Text] [Related]
32. Characteristics of spinal and bulbar muscular atrophy in South Korea: a cross-sectional study of 157 patients. Cho HJ; Shin JH; Park YE; Sohn E; Nam TS; Kang MG; Park JM; Park D; Park JS Brain; 2023 Mar; 146(3):1083-1092. PubMed ID: 35639850 [TBL] [Abstract][Full Text] [Related]
33. X-linked spinal and bulbar muscular atrophy without proximal atrophy. Boz C; Sahin N; Kalay E; Velioglu S; Ozmenoglu M Clin Neurol Neurosurg; 2002 Dec; 105(1):14-7. PubMed ID: 12445917 [TBL] [Abstract][Full Text] [Related]
34. Decreased Peak Expiratory Flow Associated with Muscle Fiber-Type Switching in Spinal and Bulbar Muscular Atrophy. Yamada S; Hashizume A; Hijikata Y; Inagaki T; Suzuki K; Kondo N; Kawai K; Noda S; Nakanishi H; Banno H; Hirakawa A; Koike H; Halievski K; Jordan CL; Katsuno M; Sobue G PLoS One; 2016; 11(12):e0168846. PubMed ID: 28005993 [TBL] [Abstract][Full Text] [Related]
35. Walking capacity evaluated by the 6-minute walk test in spinal and bulbar muscular atrophy. Takeuchi Y; Katsuno M; Banno H; Suzuki K; Kawashima M; Atsuta N; Ito M; Watanabe H; Tanaka F; Sobue G Muscle Nerve; 2008 Aug; 38(2):964-71. PubMed ID: 18642379 [TBL] [Abstract][Full Text] [Related]
36. Cross-sectional and longitudinal analysis of an oxidative stress biomarker for spinal and bulbar muscular atrophy. Mano T; Katsuno M; Banno H; Suzuki K; Suga N; Hashizume A; Tanaka F; Sobue G Muscle Nerve; 2012 Nov; 46(5):692-7. PubMed ID: 22941760 [TBL] [Abstract][Full Text] [Related]
37. Pathogenesis-targeting therapeutics for spinal and bulbar muscular atrophy (SBMA). Suzuki K; Kastuno M; Banno H; Sobue G Neuropathology; 2009 Aug; 29(4):509-16. PubMed ID: 19486304 [TBL] [Abstract][Full Text] [Related]
38. Long-term disability and prognosis in dentatorubral-pallidoluysian atrophy: a correlation with CAG repeat length. Hasegawa A; Ikeuchi T; Koike R; Matsubara N; Tsuchiya M; Nozaki H; Homma A; Idezuka J; Nishizawa M; Onodera O Mov Disord; 2010 Aug; 25(11):1694-700. PubMed ID: 20589872 [TBL] [Abstract][Full Text] [Related]
39. An open trial of long-term testosterone suppression in spinal and bulbar muscular atrophy. Yamamoto T; Yokota K; Amao R; Maeno T; Haga N; Taguri M; Ohtsu H; Ichikawa Y; Goto J; Tsuji S Muscle Nerve; 2013 Jun; 47(6):816-22. PubMed ID: 23512333 [TBL] [Abstract][Full Text] [Related]
40. Elevated creatine kinase and transaminases in asymptomatic SBMA. Sorenson EJ; Klein CJ Amyotroph Lateral Scler; 2007 Feb; 8(1):62-4. PubMed ID: 17364438 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]